文献速递腹部技术与安全US

进行性肝纤维化OGTLKO小鼠模型的肝脏硬度特征

Liver Stiffness Characterization of OGTLKO Mouse Model of Progressive Liver Fibrosis.
PubMed 文献 · J Ultrasound Med · 2025-12-04

本研究对5至8周龄的肝脏特异性OGT敲除(OGTLKO)小鼠每周进行剪切波弹性成像(SWE),使用高频临床前超声系统VevoF2和临床参考系统Aixplorer测量肝硬度,并与离体肝组织学纤维化评分及纤维化相关基因转录本进行对照。结果显示肝硬度进行性升高,与组织学纤维化评分强相关(R²>0.78),且两种设备测量结果一致(Pearson r=0.92)。

要点

  • OGTLKO小鼠肝硬度随周龄进行性升高,与组织学纤维化评分强相关(R²>0.78)。
  • VevoF2与临床系统Aixplorer的SWE测值高度一致(Pearson r=0.92)。
  • SWE可用于无创追踪小鼠肝纤维化进展并与离体病理及基因表达对照。

核心结论

  • 在OGTLKO小鼠肝损伤模型中,用SWE追踪肝纤维化硬度是可靠工具,且与离体组织学及基因表达结果相关,有助于在MASH临床前模型中理解疾病进展和评估治疗。

研究设计与样本

  • 对5至8周龄OGTLKO小鼠每周进行无创SWE监测,使用高频临床前超声系统VevoF2和临床参考系统Aixplorer,假设肝脏为均匀、各向同性且纯弹性,并与离体肝组织学评分及主要基因转录本对照。

诊断标准与关键数值

  • 肝硬度测量值与组织学纤维化评分强相关(R²>0.78)。
  • 肝硬度测量值与纤维化相关基因Col3a1、Col6a1表达相关。
  • VevoF2与Aixplorer的SWE测量值一致(Pearson r=0.92)。

临床应用与阅片要点

  • 作者认为,在MASH临床前模型中用SWE无创追踪肝硬度是评估纤维化进展和治疗的有价值工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: O-GlcNAcylation plays a key regulatory role in hepatic physiology, and its disruption leads to fibrosis in liver-specific OGT knockout mice (OGTLKO), making this model valuable for studying advanced metabolic dysfunction-associated steatohepatitis (MASH). Our objective is to demonstrate that shear wave elastography (SWE) is a suitable non-invasive tool to characterize and follow this mouse model of liver injury.

METHODS: We weekly monitored non-invasively liver fibrosis progression in OGTLKO mice from 5 to 8 weeks of age, using SWE on both a high-frequency preclinical ultrasound system (VevoF2), and a clinical reference system (Aixplorer) and assuming the liver as homogeneous, isotropic and purely elastic. Stiffness measurements were then confronted with ex vivo liver histological scoring and major gene transcripts associated with the development of the pathology.

RESULTS: Weekly liver stiffness measurements demonstrated a progressive increase, correlating strongly with histological fibrosis scores (R2 > 0.78) and fibrosis-related gene expression (Col3a1, Col6a1). The high-resolution imaging capability of the VevoF2 allowed precise anatomical exploration while delivering SWE measurements consistent with the clinical device (Pearson r = 0.92).

CONCLUSION: Our study confirms that following liver stiffness fibrosis by SWE in a mouse model of liver injury is a valuable tool that correlates with ex vivo findings. This approach facilitates a better understanding of disease progression and therapeutic evaluation in preclinical models of MASH.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Renault G, Chinchilla L, Massengo L, et al. Liver Stiffness Characterization of OGTLKO Mouse Model of Progressive Liver Fibrosis. J Ultrasound Med. 2025. PMID: 41342519. doi:10.1002/jum.70146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。